On December 7, 2020, the Accelerate Cures/Treatments for All Dementias (ACT-AD) coalition held a webinar in collaboration with the Lewy Body Dementia Association. The hour-long webinar had presentations from the world’s foremost Lewy Body dementia (LBD) experts for discussions on LBD as a priority for drug development, the genetic overlap between LBD and other types of dementia, and LBD biomarkers. Learn more about ACT-AD at act-ad.org.